USPTO serial 98097064
SANGUINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 24, 2024
- Examiner
- SHANOSKI, JOANNA MARIE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SANGUINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elizabeth Oliner
Elizabeth Oliner OLINER LAW345 GROVE STREET, 2ND FLOORSAN FRANCISCO, CA 94102United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Research laboratory analysis of biospecimens for cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research; Research laboratory services providing biospecimen analysis, cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research; Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research in the fields of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology related to biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications; Providing an online searchable database in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology and health for scientific research purposes; Providing an online searchable database in the field of biospecimen and data collection for scientific research purposes; Providing information about medical research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology for purposes including biomarker discovery and validation, drug discovery and development, diagnostics development, and other translational applications; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Scientific laboratory services; Scientific research for medical purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications; Scientific research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, oncology and health research; Providing biospecimen collection and data collection for scientific research purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 24, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 24, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 5, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 5, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 16, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 26, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 3, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 3, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 3, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 3, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 29, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 29, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 29, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 2, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 2, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 2, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 2, 2024 | RTTP | RESTORE TO TEAS PLUS | — |
| Jul 2, 2024 | RFTP | REMOVED FROM TEAS PLUS | — |
| Jun 12, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 12, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 22, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 21, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 25, 2023 | NWAP | NEW APPLICATION ENTERED | — |